Recap: AVEO Pharmaceuticals Q1 Earnings


AVEO Pharmaceuticals AVEO reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


AVEO Pharmaceuticals missed estimated earnings by 20.0%, reporting an EPS of $-0.3 versus an estimate of $-0.25.

Revenue was up $19.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 8.5% increase in the share price the next day.

Here's a look at AVEO Pharmaceuticals's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.29 -0.36 -0.45 -0.55
EPS Actual -0.21 -0.30 -0.40 -0.81
Revenue Estimate 17.93M 13.80M 8.94M 1.01M
Revenue Actual 17.65M 15.17M 7.56M 1.92M

To track all earnings releases for AVEO Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: EarningsNewsBZI-Recaps